Evaluating the Utility of Trefoil Factor 1 as a Mammary-Specific Immunostain Compared and in Conjunction With GATA-3 and Mammaglobin in the Distinction Between Carcinoma of Breast and Lung | Zendy

J. Mitchell Wells | Zendy; Paula S. Ginter | Zendy; Yifang Liu | Zendy; Zhengming Chen | Zendy; Navneet Narula | Zendy; Sandra J. Shin | Zendy

Open Access

Evaluating the Utility of Trefoil Factor 1 as a Mammary-Specific Immunostain Compared and in Conjunction With GATA-3 and Mammaglobin in the Distinction Between Carcinoma of Breast and Lung

Author(s) -

J. Mitchell Wells,

Paula S. Ginter,

Yifang Liu,

Zhengming Chen,

Navneet Narula,

Sandra J. Shin

Publication year - 2015

Publication title -

american journal of clinical pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.859

H-Index - 128

eISSN - 1943-7722

pISSN - 0002-9173

DOI - 10.1309/ajcpc7fa3ihypepf

Subject(s) - mammaglobin , medicine , breast carcinoma , carcinoma , mammary carcinoma , mammary gland , lung , pathology , immunostaining , oncology , breast cancer , immunohistochemistry , cancer

The distinction between metastatic breast carcinomas (BCs) and primary lung carcinomas (PLCs) can be difficult. This study tested the utility of trefoil factor 1 (TFF1) for this purpose and compared it with mammaglobin and GATA protein binding 3 (GATA-3).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research